B cell encounters with apoptotic cells

References

• Ramos-Casals M., Sanz I., Bosch X., Stone J. H., Khamashta M. A.. B-cell-depleting therapy in systemic lupus erythematosus. Am. J. Med.. 2012; 125:327–336.
   PubMed Web of Science ®Google Scholar
• Vincent F. B., Morand E. F., Mackay F.. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus. Immunol. Cell Biol.. 2012; 90:293–303.
   PubMed Web of Science ®Google Scholar
• Frohlich K., Holle J. U., Aries P. M., Gross W. L., Moosig F.. Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma. Ann. Rheum. Dis.. 2011; 70:1344–1345.
   PubMed Web of Science ®Google Scholar
• Mansoor F., Ali A., Ali R.. Binding of circulating SLE autoantibodies to oxygen free radical damaged chromatin. Autoimmunity. 2005; 38:431–438.
   PubMed Web of Science ®Google Scholar
• Gaipl U. S., Munoz L. E., Grossmayer G., . Clearance deficiency and systemic lupus erythematosus (SLE). J. Autoimmun.. 2007; 28:114–121.
   PubMed Web of Science ®Google Scholar
• Cohen P. L., Caricchio R., Abraham V., . Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med.. 2002; 196:135–140.
   PubMed Web of Science ®Google Scholar
• Cocca B. A., Cline A. M., Radic M. Z.. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol.. 2002; 169:159–166.
   PubMed Web of Science ®Google Scholar
• Cocca B. A., Seal S. N., D'Agnillo P., . Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc. Natl. Acad. Sci. USA. 2001; 98:13826–13831.
   PubMed Web of Science ®Google Scholar
• Catera R., Silverman G. J., Hatzi K., . Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol. Med.. 2008; 14:665–674.
   PubMed Web of Science ®Google Scholar
• Lanemo Myhrinder A., Hellqvist E., Sidorova E., . A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 2008; 111:3838–3848.
   PubMed Web of Science ®Google Scholar
• Silverman G. J., Shaw P. X., Luo L., . Neo-self antigens and the expansion of B-1 cells: lessons from atherosclerosis-prone mice. Curr. Top. Microbiol. Immunol.. 2000; 252:189–200.
   PubMed Web of Science ®Google Scholar
• Griffin D. O., Holodick N. E., Rothstein T. L.. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70. J. Exp. Med.. 2011; 208:67–80.
   PubMed Web of Science ®Google Scholar
• Capolunghi F., Cascioli S., Giorda E., . CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol.. 2008; 180:800–808.
   PubMed Web of Science ®Google Scholar
• Aranburu A., Ceccarelli S., Giorda E., . TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J. Immunol.. 2010; 185:7293–7301.
   PubMed Web of Science ®Google Scholar
• Feng C. S., Ng M. H., Szeto R. S., Li E. K.. Bone marrow findings in lupus patients with pancytopenia. Pathology. 1991; 23:5–7.
   PubMed Web of Science ®Google Scholar
• Pereira R. M., Velloso E. R., Menezes Y., . Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clin. Rheumatol.. 1998; 17:219–222.
   PubMed Web of Science ®Google Scholar
• Baumann I., Kolowos W., Voll R. E., . Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum.. 2002; 46:191–201.
   PubMed Web of Science ®Google Scholar
• Rahman Z. S., Shao W. H., Khan T. N., Zhen Y., Cohen P. L.. Impaired apoptotic cell clearance in the germinal center by Mer-deficient tingible body macrophages leads to enhanced antibody-forming cell and germinal center responses. J. Immunol.. 2010; 185:5859–5868.
   PubMed Web of Science ®Google Scholar
• Hepburn A. L., Lampert I. A., Boyle J. J., . In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann. Rheum. Dis.. 2007; 66:1106–1109.
   PubMed Web of Science ®Google Scholar
• Nakou M., Knowlton N., Frank M. B., . Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. Arthritis Rheum.. 2008; 58:3541–3549.
   PubMed Web of Science ®Google Scholar
• Xu H., Li H., Suri-Payer E., Hardy R. R., Weigert M.. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J. Exp. Med.. 1998; 188:1247–1254.
   PubMed Web of Science ®Google Scholar
• Pisetsky D. S., Lipsky P. E.. Microparticles as autoadjuvants in the pathogenesis of SLE. Nat. Rev. Rheumatol.. 2010; 6:368–372.
   PubMed Web of Science ®Google Scholar
• Morbach H., Singh S. K., Faber C., Lipsky P. E., Girschick H. J.. Analysis of RAG expression by peripheral blood CD5+and CD5- B cells of patients with childhood systemic lupus erythematosus. Ann. Rheum. Dis.. 2006; 65:482–487.
   PubMed Web of Science ®Google Scholar
• Monestier M., Zouali M.. Receptor revision and systemic lupus. Scand. J. Immunol.. 2002; 55:425–431.
   PubMed Web of Science ®Google Scholar
• Rahman Z. S.. Impaired clearance of apoptotic cells in germinal centers: implications for loss of B cell tolerance and induction of autoimmunity. Immunol. Res.. 2011; 51:125–133.
   PubMed Web of Science ®Google Scholar
• Hamel K. M., Liarski V. M., Clark M. R.. Germinal center B-cells. Autoimmunity. 2012; 45:333–347.
   PubMed Web of Science ®Google Scholar
• Shaw P. X., Goodyear C. S., Chang M. K., Witztum J. L., Silverman G. J.. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J. Immunol.. 2003; 170:6151–6157.
   PubMed Web of Science ®Google Scholar
• Nagata S.. DNA degradation in development and programmed cell death. Annu. Rev. Immunol.. 2005; 23:853–875.
   PubMed Web of Science ®Google Scholar
• Pisetsky D. S., Gauley J., Ullal A. J.. Microparticles as a source of extracellular DNA. Immunol. Res.. 2011; 49:227–234.
   PubMed Web of Science ®Google Scholar
• Schiller M., Bekeredjian-Ding I., Heyder P., . Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ.. 2008; 15:183–191.
   PubMed Web of Science ®Google Scholar
• Bekeredjian-Ding I., Jego G.. Toll-like receptors–sentries in the B-cell response. Immunology. 2009; 128:311–323.
   PubMed Web of Science ®Google Scholar
• Miao E. A., Rajan J. V., Aderem A.. Caspase-1-induced pyroptotic cell death. Immunol. Rev.. 2011; 243:206–214.
   PubMed Web of Science ®Google Scholar
• Ehlers M., Fukuyama H., McGaha T. L., Aderem A., Ravetch J. V.. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med.. 2006; 203:553–561.
   PubMed Web of Science ®Google Scholar
• Capolunghi F., Rosado M. M., Cascioli S., . Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. Rheumatology (Oxford). 2010; 49:2281–2289.
   PubMed Web of Science ®Google Scholar
• Avalos A. M., Busconi L., Marshak-Rothstein A.. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity. 2010; 43:76–83.
   PubMed Web of Science ®Google Scholar
• Heyder P., Bekeredjian-Ding I., Parcina M., . Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha. Autoimmunity. 2007; 40:331–332.
   PubMed Web of Science ®Google Scholar
• Ronnblom L., Eloranta M. L., Alm G. V.. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity. 2003; 36:463–472.
   PubMed Web of Science ®Google Scholar
• Jego G., Palucka A. K., Blanck J. P., . Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 2003; 19:225–234.
   PubMed Web of Science ®Google Scholar
• Poeck H., Wagner M., Battiany J., . Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood. 2004; 103:3058–3064.
   PubMed Web of Science ®Google Scholar
• Fransen J. H., Hilbrands L. B., Jacobs C. W., . Both early and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity. 2009; 42:325–327.
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G., Shoenfeld Y.. Infections and SLE. Autoimmunity. 2005; 38:473–485.
   PubMed Web of Science ®Google Scholar
• Lampropoulou V., Calderon-Gomez E., Roch T., . Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol Rev. 2010; 233:146–161.
   PubMedGoogle Scholar
• Chaturvedi A., Dorward D., Pierce S. K.. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity. 2008; 28:799–809.
   PubMed Web of Science ®Google Scholar
• Leadbetter E. A., Rifkin I. R., Hohlbaum A. M., . Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002; 416:603–607.
   PubMed Web of Science ®Google Scholar
• Hartley S. B., Cooke M. P., Fulcher D. A., . Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell. 1993; 72:325–335.
   PubMed Web of Science ®Google Scholar
• Isnardi I., Ng Y. S., Srdanovic I., . IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity. 2008; 29:746–757.
   PubMed Web of Science ®Google Scholar
• Miles K., Heaney J., Sibinska Z., . A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci USA. 2012; 109:887–892.
   PubMed Web of Science ®Google Scholar
• Iwata Y., Matsushita T., Horikawa M., . Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011; 117:530–541.
   PubMed Web of Science ®Google Scholar
• Fillatreau S., Sweenie C. H., McGeachy M. J., Gray D., Anderton S. M.. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol.. 2002; 3:944–950.
   PubMed Web of Science ®Google Scholar
• Yanaba K., Bouaziz J. D., Matsushita T., Tsubata T., Tedder T. F.. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol.. 2009; 182:7459–7472.
   PubMed Web of Science ®Google Scholar
• Busconi L., Bauer J. W., Tumang J. R., . Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9. J. Immunol.. 2007; 179:7397–7405.
   PubMed Web of Science ®Google Scholar